Page last updated: 2024-11-02

phenobarbital and Precursor Cell Lymphoblastic Leukemia-Lymphoma

phenobarbital has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research Excerpts

ExcerptRelevanceReference
"A possible pharmacokinetic interaction between teniposide and anticonvulsant medications was evaluated in pediatric patients."1.28Increased teniposide clearance with concomitant anticonvulsant therapy. ( Baker, DK; Christensen, ML; Evans, WE; Pui, CH; Relling, MV; Rodman, JH, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, DK1
Relling, MV1
Pui, CH1
Christensen, ML1
Evans, WE1
Rodman, JH1

Other Studies

1 other study available for phenobarbital and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Increased teniposide clearance with concomitant anticonvulsant therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:2

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Int

1992